Document Detail

Emerging therapies for heart failure: renal mechanisms and effects.
MedLine Citation:
PMID:  20803357     Owner:  NLM     Status:  In-Data-Review    
Improved understanding of the pathophysiology of salt and water homeostasis has provided a foundation for explaining the renal mechanisms of emerging therapies for heart failure, as well as why renal function might potentially be improved or harmed. These aspects are reviewed in this article for a number of newer therapies including adenosine, endothelin, and vasopressin receptor antagonists, as well as extracorporeal ultrafiltration. An appreciation of the complexity and sometimes opposing pathways of these approaches may explain their limited efficacy in early trials, in which there has not been a substantial improvement in patient or renal outcomes. In that there is often a balance between beneficial and maladaptive receptor actions and neurohumoral responses, this physiologic approach also provides insight into the rationale for combining therapies. Multi-agent strategies may thus maximize their effectiveness while minimizing adverse effects and tolerance. In this paper, the theoretical impact of the emerging agents based on their mechanism of action and pathophysiology of the disease is initially addressed. Then, the available clinical evidence for each class of drugs is reviewed with special emphasis on their effect on kidney-related parameters. Finally, a general overview of the complexity of the interpretation of trials is offered along with a number of potential explanations for the observed results.
Amir Kazory; Edward A Ross
Related Documents :
10970977 - The evaluation of corticosteroid therapy in conjunction with plasma exchange in the tre...
2818117 - Refractory potassium repletion due to cisplatin-induced magnesium depletion.
19591857 - Epidemiological, clinical and therapeutic aspects of bothrops asper bites.
24981817 - Inflammatory processes in renal fibrosis.
12669737 - Pharmacokinetics of alendronate: an overview.
22058067 - Variation in initial kidney replacement therapy for end-stage renal disease due to lupu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Heart failure reviews     Volume:  17     ISSN:  1573-7322     ISO Abbreviation:  Heart Fail Rev     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9612481     Medline TA:  Heart Fail Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1-16     Citation Subset:  IM    
Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, 1600 SW Archer Road, Box 100224, Gainesville, FL, 32610-0224, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of the effect of rapid crystalloid infusion on stroke volume variation and pleth variabil...
Next Document:  Obstetrical and neonatal outcomes of pregnancies following gastric bypass surgery: a retrospective c...